Completed OBSERVATIONAL NCT03379454

The Impact of Melanoma and Drug Treatment in the Real World

Sponsor: Melanoma UK

Conditions Melanoma

Updated 9 times since 2018 Last updated: Mar 16, 2023 Started: Oct 25, 2017 Primary completion: Dec 6, 2021 Completion: Dec 6, 2021

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT03379454, this observational or N/A phase trial focuses on Melanoma and remains completed. Sponsored by Melanoma UK, it has been updated 9 times since 2017, reflecting limited change activity. This study contributes to the evolving evidence base for cancer treatment protocols.

Status Flow

Change History

9 versions recorded

Sep 2024 — Present [monthly]

Completed
Jul 2024 — Sep 2024 [monthly]

Completed
Apr 2023 — Jul 2024 [monthly]

Completed

Status: Recruiting → Completed
Nov 2021 — Apr 2023 [monthly]

Recruiting
Jan 2021 — Nov 2021 [monthly]

Recruiting

▶ Show 4 earlier versions

Jan 2020 — Jan 2021 [monthly]

Recruiting
Jun 2018 — Jan 2020 [monthly]

Recruiting
Apr 2018 — Jun 2018 [monthly]

Recruiting

Phase: NA → None
Jan 2018 — Apr 2018 [monthly]

Recruiting NA

First recorded

Oct 2017

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Melanoma UK
Royal Marsden NHS Foundation Trust
Vitaccess Ltd

Data source: Vitaccess Ltd

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Oxford, United Kingdom